The company behind a cancer cell simulation platform has raised £17.3 million Series A financing to advance programmes and partnerships towards the clinic. Based in London with offices in Cambridge and Budapest, Hungary, Turbine’s trademarked Simulated Cell platform identifies novel cancer treatments and high unmet need patient groups.It says this allows it to target its … Continue reading Cancer cell simulation platform raises Series A funding